首页|期刊导航|护理研究|直肠癌病人新辅助化疗期间的症状群轨迹及其与术后康复指标的相关性研究

直肠癌病人新辅助化疗期间的症状群轨迹及其与术后康复指标的相关性研究OA

Symptom cluster trajectories during neoadjuvant chemotherapy and their association with postoperative recovery outcomes in rectal cancer patients

中文摘要英文摘要

目的:探讨直肠癌病人新辅助化疗期间症状群轨迹,并分析其与病人术后康复指标的相关性.方法:采用便利抽样法,于2024年4月—12月选取上海市某三级甲等医院收治的120例直肠癌病人作为研究对象.于新辅助化疗开始前(T1)、第1个化疗周期结束后(T2)、第2个化疗周期结束后(T3)、第3个化疗周期结束后(T4)、术前3~5 d(T5)对病人症状负担进行评估.采用探索性因子分析法提取症状群,通过潜类别增长模型(LCGM)识别症状群的轨迹类别,并比较直肠癌病人不同症状群轨迹类别的术后体重、饮食类型、伤口恢复情况、排便功能、并发症严重程度情况.结果:直肠癌病人5个时间点均稳定存在3类症状群,分别为神经毒性核心症状群、胃肠道反应症状群及心理应激症状群,累计方差贡献率为 66.71%~80.60%,病人在 T3时症状负担升高,T4时达峰值.LCGM识别出病人神经毒性核心症状群有3个轨迹类别,胃肠道反应症状群有2个轨迹类别,心理应激症状群有2个轨迹类别.病人神经毒性核心症状群不同轨迹类别的体重、饮食类型、排便功能、并发症严重程度比较,差异均有统计学意义(均P<0.05);胃肠道反应症状群不同轨迹类别的体重、排便功能、并发症严重程度比较,差异均有统计学意义(均P<0.05);心理应激症状群不同轨迹类别的体重、饮食类型、伤口恢复情况比较,差异均有统计学意义(均P<0.05).结论:直肠癌新辅助化疗病人症状群呈进行性加重趋势且存在群体异质性,各症状群的轨迹类别对病人的术后康复指标具有一定影响.

Objective:To investigate the trajectories of symptom clusters in rectal cancer patients undergoing neoadjuvant chemotherapy and to analyze their correlation with postoperative recovery indicators.Methods:A convenience sampling method was used to select 120 rectal cancer patients admitted to a tertiary grade A hospital in Shanghai city from April to December 2024 as study subjects.Patient symptom burden was assessed at five time points,namely before neoadjuvant chemotherapy(T1),after the first chemotherapy cycle(T2),after the second chemotherapy cycle(T3),after the third chemotherapy cycle(T4),and 3-5 days before surgery(T5).Exploratory factor analysis was employed to extract symptom clusters.Latent class growth modeling(LCGM)was used to identify the trajectory classes of the symptom clusters.Postoperative recovery indicators,including body weight,diet type,wound healing status,bowel function,and complication severity,were compared among different trajectory classes of symptom clusters.Results:There three stable symptom clusters were consistently identified across the five time points in rectal cancer patients,namely a core neurotoxicity symptom cluster,a gastrointestinal reaction symptom cluster,and a psychological stress symptom cluster.The cumulative variance contribution rate ranged from 66.71%to 80.60%.Patient symptom burden increased at T3 and peaked at T4.LCGM identified three trajectory classes for the core neurotoxicity symptom cluster,two for the gastrointestinal reaction symptom cluster,and two for the psychological stress symptom cluster.Statistically significant differences(all P<0.05)were found in body weight,diet type,bowel function,and complication severity among different trajectory classes of the core neurotoxicity symptom cluster.Significant differences(all P<0.05)were found in body weight,bowel function,and complication severity among different trajectory classes of the gastrointestinal reaction symptom cluster.Significant differences(all P<0.05)were found in body weight,diet type,and wound healing status among different trajectory classes of the psychological stress symptom cluster.Conclusions:Symptom clusters in rectal cancer patients undergoing neoadjuvant chemotherapy show a progressively worsening trend with group heterogeneity.The trajectory classes of each symptom cluster have a certain impact on patients' postoperative recovery indicators.

郭文悦;罗珏;张雯;张晓菊

复旦大学附属肿瘤医院,上海 200032||复旦大学上海医学院复旦大学附属肿瘤医院,上海 200032||复旦大学上海医学院复旦大学附属肿瘤医院,上海 200032||复旦大学上海医学院复旦大学附属肿瘤医院,上海 200032||复旦大学上海医学院

直肠癌新辅助化疗症状群潜类别增长模型术后康复

rectal cancerneoadjuvant chemotherapysymptom clusterslatent class growth modelpostoperative recovery

《护理研究》 2026 (14)

2414-2422,9

上海市卫生健康委员会卫生行业临床研究专项项目,编号:202340261复旦大学-复星护理科研基金项目,编号:FNF202335

10.12102/j.issn.1009-6493.2026.14.004

评论